A Phase Ii, Open-Label, Extension Study of Long-Term Patisiran Treatment in Patients with Hereditary Transthyretin-Mediated (Hattr) Amyloidosis

AuthID
 P-00S-ESG
14
Author(s)
Adams, D
·
Waddington Cruz, M
·
Buades, J
·
Polydefkis, M
·
Wang, JJ
·
Chen, JH
·
Sweetser, MT
·
Suhr, OB
Document Type
Article
Year published
2020
Published
in ORPHANET JOURNAL OF RARE DISEASES, ISSN: 1750-1172
Volume: 15, Issue: 1
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 32641071
Scopus: 2-s2.0-85087693350
Wos: WOS:000551966000001
Source Identifiers
ISSN: 1750-1172
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service